Reddit Posts
GD*HG: Ready to take off? 30 sec to the MOON!
Bearish $GHRS FDA Clinical Hold GH Research Provides Updates and Guidance on its Clinical Development Program for GH001
WiMi Hologram Cloud (WIMI) developed its AI computing technology
AIGC Brings The Productivity: The development trend of WIMI become more distinct
Nvidia stock breaks out, flashing bullish sign, with earnings due — Is it a buy?
Nvidia earnings to offer first true glimpse of the AI windfall
Wall Street analysts expect Nvidia stock ($NVDA) to surge 25%; are they underestimating?
BTBT is the Most Viable Cheap Public Mining Company
A 23-Year-Old Man Flees With His Father's GH 9,500 And Leaves This Behind (See Details)
Glass House Brands Closes Morro Bay Natural Healing Center Dispensary Acquisition 09/15/2022 $GLASF
$BTCM Why is Bit Mining moving today? As $ETH.X is hitting $2,000 this week, Bit Mining is ether focused, it mines 25,000 ether per year, 4.8 GH/s modern facility. Has 82.5MW bitcoin facility in Ohio and is Top 10 World Mining Pool business. It Acquired Microchip Producer in May 2022. PT $2
Ethereum ripping back to $2,000 - check and load $BTCM early before others
$BTCM As $ETH.X is gaining momentum and has doubled last weeks, Bit Mining is a blockchain stock to watch. In addition to $BTC.X , it has 4,800 GH/s Ethereum mining capacity in Hong Kong. Company in addition to mining it produces chips. Worth looking!
$BTCM Free float 57m, SP .72 - Check this one guys, this looks ready to squeeze.
$GLASF Glass House brands Inc. Completes Acquisition....
UCB to acquire Zogenix $ZGNX for $1.9 billion, Bright Minds Biosciences' ($DRUG )BMB-101 for the same indication to hit clinical trials in a couple of months
Sleeping on anti-aging labs can cause you to die younger and broke.
Sleeping on anti-aging labs can cause you to die younger and broke.
Sleeping on anti-aging labs can cause you to die younger and broke.
Powerbridge Technologies Establishes Cryptocurrency Mining Fleets for Bitcoin and Ethereum in Hong Kong $PBTS
SOS Announces Completion of Phase I of Leibodong Mine and Receipt of 575 ETH Mining Rigs
$AEZS Aeterna Zentaris Potential to Move Higher (Currently 1.55) (DD)
Mentions
Been a large position in LEEF for months now hoping the stock performance will follow GH’s trajectory. Had you seen yesterdays LEEF update: https://youtu.be/iR3pqQGANo4?si=SBVHiBlLAGurqzpm
One of these days AAPL calls have to pay off right? R I GH T??
After a 450% sprint, I quietly relieved $GH of some excess baggage ;) Took a modest toe-dip into $KRKNF.
always liked GH, been posting about it in many comments urging people to buy when it was 40
I see you made a post for DXCM. Is GH a new one you like?
oh i forgot to mention GH is a likely takeover target, just look at EXAS last month. Although, i have a feeling GH management would reject any bid as they know they can build the next 100b company
in short - GH will be the near monopoly in cancer screening few years from now and DXCM is comically undervalued 1 year price target
I commented in the last thread and was openly skeptical. I’ve got to give you credit, you nailed that one. Investing in health-related companies makes me nervous, but I’ll at least take a look at these two. Any thoughts on why you’re optimistic on GH and DXCM? Timeframes for your price targets?
IMO, RXRX is a very Cathie Wood stock. It conceptually sounds appealing/exciting theme but when you look at ARKG over the last 5 years, you can see the "hype years" and you can see the years where healthcare is struggling and fundamentals matter. In the latter (2021, 2022, 2024) , the fund has been at the bottom of the category. When you look at the long-term? 3YR/5YR/10YR the fund is at or near the bottom of the category. IMO, if you have one of the greatest growth investing periods that I've ever invested in and the 5 year chart is just a continual erosion, there's something amatter. Recursion merged with peer Exscientia in August 2024. If this was such a compelling area, why would that company sell itself way off the highs? The merger hasn't seemed to help RXRX either. In terms of trials: REC-994 (Cerebral Cavernous Malformation): Recursion's lead candidate failed to demonstrate convincing efficacy in Phase 2. While it met the primary goal of safety, long-term extension data showed no promising trends in MRI or functional outcomes, becoming indistinguishable from natural history. REC-2282 (Neurofibromatosis Type 2): Development was halted after preliminary Phase 2/3 data from the POPLAR-NF2 trial showed limited tumor shrinkage and clinical activity. While the 40mg dose passed a futility threshold, the totality of the data did not justify further investment. REC-3964 (C. difficile Infection): Despite being the first new chemical entity developed through the "RecursionOS" platform, this Phase 2 program was discontinued in May 2025. The company cited a strategic decision to focus on other areas rather than clinical setbacks. REC-4881 (Solid Tumors): A pause was announced for this drug specifically targeting solid tumors, though it remains in development for other indications like FAP (Familial Adenomatous Polyposis) where it has shown more positive results. The company has been around for a bit now and when you look at the pipeline, there is one thing in phase 2, nothing in phase 3, the rest are all phase 1/pre clinical. Looking at a discussion on r/biotech: "Think it came up in another thread, but they just don't give the vibe they know what they're doing in clinical development. It's hard to say it exactly. But somehow they don't talk like they understand how hard it is to actually get something to market and what needs to be done to make that happen." (https://www.reddit.com/r/biotech/comments/1f8icsi/with_few_specifics_recursion_underwhelms_with/ - another thread: https://www.reddit.com/r/biotech/comments/1klmsi1/what_do_you_guys_think_of_recursion/) Also, I wasn't even aware the CEO stepped down a couple mo ago. Again, not saying this is a zero and don't want to be harsh but I just think this is one of those things where the results haven't matched the hype. The stock is 33% short (which says something) so any good news and could get a short squeeze. There is some cash to get through the year and there is a pipeline, but nothing in that pipeline is in stage 3/is seeming to generate that much excitement. IMO, AI around genetic testing (TEM, GH, former ILMN spin off/source of controversy GRAL, NTRA) has been an investment theme that has delivered a lot more than AI drug discovery - at least at this point.
GH will double within a year. PT 200 I said it would double when it was 40 on this sub, look at it now
i opened a position in GH at 48 and doubled down at 35, now it’s 100. posted that it would double when it was 50 in this sub
GH will at least 5x within 5 years. they will be the monopoly in cancer screening for all cancers by then. i estimate 2030 sales to be 5.4b, they are currently at 902m ttm and CAGR has ticked up after the release of guardant shield (colon cancer screening, which has been historically underpenetrated in the cancer screening population due to patient reluctance to do colonoscopies) i posted about it here and other subs when it was 40. said it would be 100 within a year and it did
you can follow my posts, i post proof and always heavily invested in my plays https://www.reddit.com/r/stocks/s/2pzoapKwCd posted the above when PEN was 220, nearly 50% return in a month been posting about GH on this sub when it was 40, now 100 currently 200k in dxcm and GH, GH will go to 200 and dxcm at least 90
100% into GH, up 150% ytd this stock will hit 200 by end of next year
🤔 Could this mean then that VSCodes agent integrations with GH Copilot just stop? Enterprise seems to be using VSCode coupled with GH Copilot Enterprise.... unless swap to Cursor? I'm trying to make sense of "no one uses it..." the standalone Copilot enrrypoint ms branded is hot garbage compared to the UIs for Perplexity, OA, and Anthropic imho
Yup im sure you know lots of 16 year olds blasting test, GH, and Tren 🤡
Why every young retards look same? Stupid north face jacket, stupid broccoli hair, crocs and 16yrs old gym bros juicing like 300mg TST and GH? Like what is wrong with all these retards?
NBIS CRWV ASTS RKLB NVDA AVGO SMTC GH I hit the f\*cking jackpot ths year, a 56% return, I'm lucky as F\*ck
At least once a year I get a huge urge to play Guitar Hero for a day. And it's something I'd love to share with my young kids, but it's a huge pain in the ass to get a functioning setup with the guitar. I know the licensing must be hell, but I really wish they would slap a greatest hits collection or whatever on the marketplace and release a new version of the GH2/3 controller.
Anyone elsze got a problem where they get into a hobby, buy a bunch of cool shit for said hobby, and then lose interest in the hobby? Looking around this room: -Panasonic GH5/Olympus PEN EP-5/Olympus OM-D EM-10 MK III camera bodies and thousands in Micro Four-Thirds lenses: Haven't taken a picture that wasn't on my phone for over a year -Pioneer DDJ-400 mix controller with lifetime Rekordbox subscription & Minilab Arturia MIDI keyboard: Haven't touched them in 2 years and in a Japanese metal phase now -DJI Air 2S/Mini 3, Ronin RS3 gimbal w/ Raveneye upgrades: Never used the gimbal and haven't flown the drones in over a year, I think my license is expired -Dreamcast w/ GDEMU upgrades: Bought it to play Jet Set Radio, realized Jet Set Radio actually sucked and my childhood memories were from Xbox One's "Jet Set Radio Future" Bambu Lab P1S 3D printer: Haven't printed anything since Halloween It looks like a Silicon Valley pawn shop in here. I need to use this shit
GH. Up 82% in the past 3 months. Just got paid so adding more. Long play. 🚀 🌕
GH, CAI, NTRA, and countless pharma companies have similarly giant repositories of patient multiomic data. Not to mention the publicly available date made available through population sequencing programs.
# DO NOT IGNORE THIS COMMENT Hello R3TR0-GH02T, your comment has been removed because your account has low karma. We have this filter in place to help protect against bots, trolls, and spammers. We might approve your post if you were not spamming/trolling/etc in some time if your post is of significant quality. Please message the mods of r/shortsqueeze using [this link](https://reddit.com/message/compose/?to=/r/Shortsqueeze&subject=Content+Approval+Because+of+Low+Karma) if you believe this is in error and you DO fit the requirements. You will not be approved for telling us you are not a bot. (Please note -- It will not be approved sooner if you message us 5 minutes after it gets removed or if you message multiple times). Also, messaging us to say that you are not a bot is not qualification for this post to be approved. Please do not message us unless you have over the approved karma limit (25). If you do not know what karma is, or how to get it, check our r/newtoreddit *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/Shortsqueeze) if you have any questions or concerns.*
https://pbs.twimg.com/media/GH86DOpXoAAp9_9?format=jpg&name=medium
https://pbs.twimg.com/media/GH86DOpXoAAp9_9.jpg
Excluding ETFs, Google’s #2 for me. Shockingly, $GH (a biotech) is #1. Both had earnings today.
## Update: Took profits on several shortly after Party Pooper Powell blurted that he doesn't want us all making money this holiday season... Closed calls early for profit today: BBIO CHRW EL GH PBF LLY GOOG EBAY ALNY I recognize that these may be premature, but it was also done to reduced my exposure and risk going into tomorrow. I dumped a bunch of my long positions as well.
Then I maybe misread. If so, im sorry. Your whole answer was with quite a hard tone while I just wanted normal conversation about investing. Investing is something beautifull and nice to talk about. Thanks I will check in on GH. I hope you are wrong on MYNZ and i will earn some money with it! I hope you earn some money as well with your portfolio!
i really wasn't but i can't change what you think and sure, put your money in $GH. i'm all in, i've been posting it in my comment history since march
i really wasn't but i can't change what you think and sure, put your money in $GH. i'm all in https://www.reddit.com/r/stocks/comments/1ja80i2/what_are_you_guys_buying/mhjf6dc/
here i'll bite since you're pretty enthusiastic and haven't done much research MYNZ main product is coloalert, which is a direct competitor to Exact sciences' cologuard. both tests use stool samples, which you basically poop in a tube and ship it back for the company to analyze. ColoAlert is offered in europe while cologuard is offered in the US the thing is, while both tests are accurate, both will lose in the long-term to Guardant Health's blood draw because of one simple reason - no one wants to handle their own poop and would much rather take a blood draw at the expense of a little accuracy. on top of that, MYNZ is half a decade behind EXAS in the US, this type of product requires an extensive sales force to propel sales and an established distribution network - on top of that, they cannot compete against GH and EXAS which already have approved insurance reimbursements and partnerships with hospitals and private payer networks. this is a losing race for MYNZ i won't even talk about their financials. they are horrid. this product is selling like shit in europe. last fiscal year, only 500k in revenues and 19m in overhead to achieve that. the company spent 17m last year in operations and only has 6m cash in the bank left. they will copy the well known playbook around this sub where they constantly dilute and dilute shareholders and then do a reverse split so they can repeat the process until even the dumbest shareholders get tired of this cycle into eventual bankruptcy do not put your money into this shit (literal shit)
A good entry into Gerresheimer. The pharmaceutical packaging specialist also for Novo. GH is poised for a rebound.
 Can you make it even harder to read?
 Give em hell kiddo
You are using Unit economics and that was viable pre GB200 - Meaning, nobody was scaling NVLink because everyone wanted blackwell. GH200 could do it but that was like an iteration that was on wait for blacwell then go. Before that there was nothing really there worth noting. Look at the sales of H100's byoCPU and that of GH200's H100's were just the way in which people knew how to bring on GPU's for use. the game has totally shifted to GPU+CPU systems that can interconnect. That's net new in a very meaningful way.
i love a good dcf. i did one for tmdx when it was 60, and it hit my PT of 120 rather quickly. also did one for PEN at 180 and hit my PT of 300 i’ll post images later, not at computer but my latest play is GH at 40 with a DCF PT of 100
you can find similar trading patterns with every stock. from my experience, they work until they don't and a new pattern emerges or just devolves into complete randomness. two stocks that i've been long on, TMDX and GH, have had very predicable trading patterns on open for about a month each where they would gap up and then violently gap back down within the first 30 minutes. then suddenly, this pattern just stopped working there's no discernable reason as to why
GH also has two co ceos and are killing it recently
Surprised no one has brought up healthcare growth names yet…PINS and GH come up a lot in my own screens. Anyone else bullish on healthcare growth going into the back half of the year?
GH is an interesting call…the cancer screening angle gives it a huge TAM if adoption scales…The challenge I see is balancing that long term potential against how much runway the market has already priced in at $66…Do you see it as more of a decade-long compounder or a near-term trade based on momentum?
$GH ive posted multiple times in this sub and many comments about how it will be $100+ a year from now. posted when it was $40, now it’s $66. they will be the monopoly in cancer screening a decade from now
I’ve got a large position in GH and haven’t sold a single share since the raid. Interesting that the management dropped the libel lawsuit against Elliot when he went public with his allegations about backdooring. My take is they preferred to focus on growing the business rather than waste resources on a time consuming and perhaps expensive lawsuit. Perhaps there was also a concern about corporate cannabis trying to squash the little guy (David vs Goliath). I might be wrong but based on: - no management has departed after the raid to my knowledge - insiders participated heavily in the refi announced shortly after the raid - previous site inspection found no issues a few months earlier - CEO has said contract with labour suppliers stipulates that all migrant workers must be of age - company was paying 25% higher rates than the standard ag worker in Cali is getting paid (sounds like “exploitation” to me!!!) - no charges have been laid; just lots of accusations being thrown around - no suspension of their license to date by the licensing board (my understanding is having minors on site of a cannabis facility is grounds for immediate suspension) - Cohodes dropped another $3M invested into GH when the sold tanked after the raid. Marc has built a reportedly stellar career on shorting companies. He would be the first to know if there was corporate shenanigans at play. I believe if his research found foul play to be going on at hand, he would have no problem with dumping his shares and going short. Like Elliot, he has a loud voice and has no hesitation to use it. Given he and his son have millions of shares and are still long is reassuring to me. I might be blinded due to having a stake in the game, but from what I’ve seen, lots of accusations flying around here and on X but nothing substantiated to date. Time will tell.
In this market even shit tier stocks are up. What makes GH special ?
tired of the shilling of meme stocks here so i'll post an underrated gem $GH will be the monopoly in cancer screening for the most aggressive cancers 5 years from now. i've been posting about this stock on multiple subs since it was $30, it just breached $60 and will at least double from this point i've personally put 90% of my portfolio in this, basically a full port
Glass House got away with a crime. Don’t just blame ICE alone. GH is going to be bankrupt once lawyers figure out their ways to sue the hell out of them.
you're choosing the wrong healthcare stocks! medical tech is where it's at medtech is carrying my portfolio - TMDX, GH, ISRG, PODD, etc
grail is undoubtedly the leader in MCED tests but that's not even worth saying anything, there are huge concerns because they are extremely unreliable and have low sensitivities for early stage cancers GH already presented data for their MCED test and it is more favorable to galleri's for many types of cancers. galleri is not even close to getting any sort of regulatory medical reimbursement and revenue has been flat QoQ since they spun off from illumina. the test is not very useful at all
GH, been holding since 20s. they will be the monopoly in cancer screening a decade from now. will easily double within a year
KRKNF, GH, AUR, IAS, and obviously RKLB
LOL. My point is the truth. > Not efficiency Ah... speed and efficiency are one in the same. > an massive support team that will work with you directly? Jensen himself said that doesn't matter since the big customers write all their own software anyways. That was in response to a question of wouldn't it be a problem that GH breaks software compatibility with everything that came before. Jensen doesn't think it's a problem. Why do you?
Can you explain your reasoning behind GH and PT? I would like to why
put a significant port of your money into GH i posted about TNDM other subreddits when it was $4 in 2017 and told everyone to hold into a price target of $60. it reached $120. i 30xed my net worth on that one play and have since then consistently outperformed the market by investing solely in confident medtech plays [https://gyazo.com/9e31bfdf1caa5be69b13fa315cd9b423](https://gyazo.com/9e31bfdf1caa5be69b13fa315cd9b423) my most recent play i posted about on reddit was TMDX at 60 and it short squeezed all the way to $150 on stellar earnings. happy to provide proof if you want. my next double bagger is GH, PT of $100 within a year, could 4x within 3 years. they will have a near monopoly in cancer screening 5 years from now enjoy it if you trust the process
put a significant port of your money into GH i posted about TNDM other subreddits when it was $4 in 2017 and told everyone to hold into a price target of $60. it reached $120. i 30xed my net worth on that one play and have since then consistently outperformed the market by investing solely in confident medtech plays [https://imgur.com/a/uQ29jep](https://imgur.com/a/uQ29jep) my most recent play i posted about on reddit was TMDX at 60 and it short squeezed all the way to $150 on stellar earnings. happy to provide proof if you want. my next double bagger is GH, PT of $100 within a year, could 4x within 3 years. they will have a near monopoly in cancer screening 5 years from now enjoy it if you trust the process
this sub is so boring these days, basically bogleheads v2 put a significant port of your money into GH i posted about TNDM other subreddits when it was $4 in 2017 and told everyone to hold into a price target of $60. it reached $120. i 30xed my net worth on that one play and have since then consistently outperformed the market by investing solely in confident medtech plays my most recent play i posted about on reddit was TMDX at 60 and it short squeezed all the way to $150 on stellar earnings. happy to provide proof if you want. my next double bagger is GH, PT of $100 within a year, could 4x within 3 years. they will have a near monopoly in cancer screening 5 years from now enjoy it if you trust the process https://imgur.com/a/uQ29jep
this sub is so boring these days, basically bogleheads v2 put a significant port of your money into GH i posted about TNDM in wsb and other subreddits when it was $4 in 2017 and told everyone to hold into a price target of $60. it reached $120. i 30xed my net worth on that one play and have since then consistently outperformed the market by investing solely in confident medtech plays (DXCM, ALGN, ABMD, ISRG, PEN) etc my most recent play i posted about on reddit was TMDX at 60 and it short squeezed all the way to $150 on stellar earnings. happy to provide proof if you want. i have an edge because i used to work for a hedge fund so i know how to build a thesis and act on it. my next double bagger is GH, PT of $100 within a year, could 4x within 3 years. they will have a near monopoly in cancer screening 5 years from now enjoy it if you trust the process
Can we not make the use of illegals and child labor about Trump targeting state-legalized weed? At best the political retribution was that GH donated to Newsom. Most likely, it was the tips ICE received that hundreds of illegals were working there. Blame California for not cracking down on the illegal grows. But there's no bigger known grow - legal or illegal - as large as GH's operations.
Once it’s back over a dollar a share, this stock is going to print money for everyone! 
GH halted at 4:01. https://www.barchart.com/story/news/33447686/canadian-investment-regulatory-organization-trading-halt-glas-a-u
I was reviewing the Glass House investors presentations yesterday, in order to determine the physical proximity of where hemp vs cannabis was being grown. I ran across this specific "advantage" that Glass House claimed, which did not age well. >Access to Labor: Located in Ventura County where access to agricultural labor is plentiful Their primary cultivation site, which is where they are doing hemp, has 6 greenhouses. They are all right next to each other. * Number 1, 5, and 6 - Operational cannabis grow * Number 2 - Retrofit for light-assisted cannabis growing * Number 3 - Vacant (rented?) * Number 4 - Hemp (used to be rented) Greenhouse 2 has a large retrofit underway, including lighting. This means construction contractors, which is another industry dominated by undocumented immigrant labor. I still find it very unlikely GH would have any undocumented 14 year olds working with regulated cannabis. I find it slightly more possible GH could have undocumented 17 year olds working with unregulated hemp. I find it most likely GH will blame any underage immigrants on-site on a local SoCal construction contractor working on their Greenhouse 2 retrofit. Either that or on workers from Greenhouse 3, if they are still renting that out to tomato growers.
I agree, I’m not advocating for the company. My original point was the optics of this are going to be what effects the share price. The financial aspect of rehiring workers will be minimal That was my point to kbarbs then manyeasy had to argue with me over stupidity I don’t own a position in GH and not a fan if them
GHK-Cu BCP157 TB500 (TB4) - these 3 compounds also fall under the name "GLOW" (they're premixed with balanced weight ratios GH secretagogues - Can help with repair of muscle, potentially other damaged parts of the body. Some others, that are more up for dispute, and more dependent person to person - NAD+ MOTS-c (to an extent)
Granted the relationship is different but MSFT also uses OpenAI across their stack, including GH Copilot which only uses other models but uses OpenAI by default. Dude is just ignorant to the fact tech companies can provide value beyond AI.
Bad sector got years. Got reamec on every attempt. My best hope here is GH. Just got FDA breakthrough status and because it’s a test you don’t need to spend nearly as much money or wait as long for FDA approval See https://investors.guardanthealth.com/press-releases/press-releases/2025/FDA-Grants-Breakthrough-Device-Designation-to-Guardant-Healths-Shield-Multi-Cancer-Detection-MCD-Test/default.aspx
I own both as well. Bought the dip on tmdx so at a 67 cost basis. GH I’ve had for a year or two now at 29 cb. Not sure I’d put either in my top 5, but probably in my top 10.
i posted TMDX here when it was 60 4 months ago and said it would double within a year. It’s 127 now GH will be a $100+ within a year
Couldn't get it here before they removed your post, but found you on GH. Thank you for sharing!
GH will be the monopoly of cancer screening 5 years from now. Personal price target 100 My last recommendation on a post like this was TMDX when it was 60, said it would double within a year (and it did in 3 months)
The last politician who I believed was going to bring down government debt was GH Bush, and he was voted out. Hartnett has terrible logic for this thesis.
Just invest in $GH instead. They’ll be the monopoly in blood based screening 10 years from now
Tell me you like throwing nonsense out there without doing it. Lyft seriously is 2nd in command when it comes to ridesharing industry. It’s definitely Ubers main competitor. Just waiting for a partnership with DoorDash or GH. Lyft isn’t your typical “no signs of worry” business.
Yes. Most will fail. As will most small cap stocks. But biotechs especially are the most binary unless they are like GH and have a steady revenue on things like tests
Bears today! [https://media3.giphy.com/media/v1.Y2lkPTc5MGI3NjExbm95dDJzYzEwYnZ6cXg5a3BhdTh1d284YW5ocGg1amN1bHE1c3I0NiZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/TgHQOqCqf9GH6/giphy.gif](https://media3.giphy.com/media/v1.Y2lkPTc5MGI3NjExbm95dDJzYzEwYnZ6cXg5a3BhdTh1d284YW5ocGg1amN1bHE1c3I0NiZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/TgHQOqCqf9GH6/giphy.gif)
EXAS and GH will loose their positions... recent Armistice fund filling shows trust on this one 222k shares @ $6.77 which is roughly $1.5M. Do they know something that we don't? https://preview.redd.it/e76hblquwnte1.png?width=619&format=png&auto=webp&s=c084a7bcc8d3c35a276043faf55137127d7ae13c
As I posted elsewhere, it's financial abuse. Trump is an abuser, and they have known tactics. He's at the isolation stage of the relationship. Europe and the world will quietly disengage as much as possible, just like friends of abusive relationships; the sympathy wears out, and they don't want the drama: "Why did you take him back? You know what he's like. You deserve each other. Good luck." Trump/ the abuser blames everything on others: "They're taking advantage of you. They're trying to destroy us. We don't need any of them. Let me introduce you to MY friends, you'll like them better." Isolating the victim increases the abuser's control over them and makes the victim more dependent on the abuser. The gaslighting works better that way: isolation, manipulation of reality, denial, inconsistency of behaviour, coercion, and creating self-doubt. The next stage is increasing control until its (literally) a choke hold. While blaming the victim, of course: "Look what you made me do." DARVO. Then what? Either escape or death. The average victim returns to their abuser 7 times before they leave for good. Let's look on the bright side; the abuse started with the GOP under Nixon, then Ford, Reagan, GH Bush, GW Bush, and Trump 1. So fingers crossed Trump 2 is the last time you go back to them. Leaving is always the most dangerous time. They'll stop at nothing to keep power over you, even kill you, if they know that this time you mean it. Victims aren't weak and stupid - they're often lonely and have no strong support structure, which is the American people in a nutshell. Abusers use their victims' strengths and vulnerabilities against them. Start calling it political abuse instead of fascism. Learn all the tactics. Look up the power and control wheel. Godspeed.
If they enter the hemp market it will be interesting to see what happens with market listing. I assume that they will have to create a parallel legal entity to handle the hemp channel such as to avoid breaching any cannabis processing and handling requirements. As such in theory they could have half the company list on the nasdaq for the hemp business and the remainder stay off the big boy exchanges. So something to consider as well if institutional money could buy into GH under this arrangement.
Near term growth prospects are far greater for this company than any other US based cannabis company if they decide to enter the hemp-THC market since it’s basically fed legal (barring a couple of states banning hemp). They were talking about putting seeds in the ground later this year if they decide to proceed with the hemp market. Risk is, of course, that they convert some greenhouse to the hemp channel, start a grow, and then have the loophole close. Florida is at least 18 months away if the next ballot initiative is successful so Trulieve has a large TAM boost potentially but have to sit tight and wait. If the tax hike goes through in Cali, the gap beteeen all the mom and pop grow ops and Glass House’ cost advantage will only grow. Unless I’ve got blinders on, I see very little downside risk to GH under either scenario and will be buying sub $5 for sure. The recent refinance deal strengthens my conviction as the number one buy on a r/r basis.
I own a cookie shop and we use DD UE and GH; DD is the worst, they take the most and give the least. The lawsuit is correct in its accusations. In order to get the highest quality service which is horrible you have to give up 30% of your sales. But that's not where it stops, there's dispatch fees, long distance delivery fee's after 11pm fee's. so you really only end up seeing about 60% of the sale price. So you have to mark it up which deters people from ordering. Their recommendation is to only mark up your prices by 10% but they still take 30% of the newmore expensive price. I'm seriously considering moving back to in house drivers
GH calls RIVN puts
How we feeling about GH?
The Baker Brothers just filed their Form 13F-HR on Feb 14, 2025, and they took a GRAL position (before Dec 31st 2024). Also Guardant GH is a player in this space. Revenue for that company is accelerating very quickly although and they don’t have a wider cancer test like the Galleri test. They tend to focus more on individual cancer tests. One question I have is, can a test receive insurance coverage BEFORE the FDA officially approves it? Probably not, right? It seems current shareholders will likely need to wait for FDA approval and the insurance coverage.
They are psychedelic medicine biotechs: Cybin, Compass, Atai, GH Research, and Optimi Health. I'm sure that sounds absolutely insane to most people, but if you've ever done psychedelics you already know the potential. One random psilocybin trip helped me to end 5 years of rampant poly drug abuse overnight. The clinical trial results these companies are producing are nothing short of incredible. The only real question is whether they can get FDA approval, and how they will scale commercially.
RFK Confirmed so I can go to the store and get my GH now? I don't have to get it from Gyna anymore?
What I'm saying is that this post's claim of hydroponics being in the future is true, NASA also does experiment with GH,but this science is old at best and not worth investing in even during the boom in hydroponic systems during the pandemic? I thought I was clear. I mean its clear even getting into the hobby, that indoor gardening is expensive and niche and its really there for hobbyists and stuff that is currently unprofitable like space exploration. If you want advice on investing into shit like this? The day that we're thinking of living on other planets is when investing in hydro is a consideration, and Canna would be your best bet if you want a "nonshit" and super reliable company and even investing in that is beyond retarded.
Study results: * Primary endpoint met, GH001 led to an ultra-rapid anti-depressant effect with a significant placebo-adjusted MADRS reduction from baseline of -15.5 on Day 8 (p<0.0001) * The majority of the patients treated with GH001 achieved remission with a 57.5% remission rate on Day 8 compared with 0% in the placebo group (p<0.0001) * All other secondary endpoints were met with clinically and statistically significant improvements on Day 8, compared with placebo * During the double-blind part, GH001 was well tolerated and no serious adverse events (SAE) were reported. There was no evidence of treatment-emergent suicidal ideation or behavior. As of January 22, 2025, no SAEs have been reported throughout the open label extension (OLE) * As of January 22, 2025, 77.8% of the OLE completers were in remission at the 6-month visit, with infrequent treatments * Patients who had remission on Day 8 after their first active treatment had a 91.7% remission rate at 6 months [https://www.globenewswire.com/news-release/2025/02/03/3019385/0/en/GH-Research-Announces-Primary-Endpoint-Met-in-Phase-2b-Trial-with-GH001-in-TRD-Demonstrating-15-5-Point-Placebo-adjusted-MADRS-Reduction.html](https://www.globenewswire.com/news-release/2025/02/03/3019385/0/en/GH-Research-Announces-Primary-Endpoint-Met-in-Phase-2b-Trial-with-GH001-in-TRD-Demonstrating-15-5-Point-Placebo-adjusted-MADRS-Reduction.html)
This is bananas [https://www.globenewswire.com/news-release/2025/02/03/3019385/0/en/GH-Research-Announces-Primary-Endpoint-Met-in-Phase-2b-Trial-with-GH001-in-TRD-Demonstrating-15-5-Point-Placebo-adjusted-MADRS-Reduction.html](https://www.globenewswire.com/news-release/2025/02/03/3019385/0/en/GH-Research-Announces-Primary-Endpoint-Met-in-Phase-2b-Trial-with-GH001-in-TRD-Demonstrating-15-5-Point-Placebo-adjusted-MADRS-Reduction.html) I'm breaking my no biotech rule on GHRS, it doubled on these results for severe depression it should do 2-3x from here. Also AMD is mad undervalued but waiting for an in on technicals
-> GH Research shares are trading higher after the company's inhalable depression treatment GH001 met the primary endpoint in its Phase 2b trial, showing symptom reduction. -> GH Research's Inhalable Depression Treatment GH001 Hits Primary Endpoint in Phase 2b Trial, Showing Symptom Reduction
01/31/2025 - 04:01 PM DUBLIN, Jan. 31, 2025 (GLOBE NEWSWIRE) — GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced that it will host a conference call and live webcast on Monday, February 3, 2025, at 8.00 a.m. EST to provide an update on data from the randomized, double-blind, placebo-controlled Phase 2b trial of GH001 in treatment-resistant depression (TRD).
Stfu about TLRY. If you want to waste money on weed stocks at least try HITI or Althea GH which have conceivable potential. Most cannabis companies aren’t profitable because they pay their staff fucking millions a year, and are too blazed to work out how to cheaply grow and distribute a fucking plant
Yes. They supply the CPU in the current GH200 systems and the upcoming GB200 systems and they will be entering the laptop market with their Mediatek collaboration with an Arm SoC.